GSS only began thinking about and then producing their COVID-19 test kits a couple of months ago. They achieved CE and TGA approvals in almost record time ( which says everything about the thoroughness of their respective applications )
Their test kits are already in use here and in Europe.
As Al. rightly points out, the global demand for COVID-19 tests is insatiable and supply is finite. Anyone who hasn't listened to the US Governors like Cuomo point this out simply isn't paying attention.
Therefore, the base case assumption should be that the market will buy every test kit that GSS can make.....as soon as its made. Full stop.
Every Lab that GSS works with creates an opportunity for them to cross sell another test for another disease. As GSS' portfolio of tests broadens, so too does their revenue opportunities.
Its as simple as that........
GSS Price at posting:
$1.81 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)